245 related articles for article (PubMed ID: 29129389)
21. Value of combined adjuvant chemotherapy and radiation on survival for stage III uterine cancer: is less radiation equal to more?
Wang CJ; Christie A; Folkert MR; Xie XJ; Albuquerque K
J Gynecol Oncol; 2018 Jul; 29(4):e49. PubMed ID: 29770620
[TBL] [Abstract][Full Text] [Related]
22. Stage I and II Endometrial Adenocarcinoma: Analysis of 2009 FIGO Staging Revision and Impact on Survival by Adjuvant Therapy.
Cahan B; Kim JH; Schultheiss TE; Wong JYC; Chen YJ
Am J Clin Oncol; 2018 Mar; 41(3):302-306. PubMed ID: 26886945
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion.
Son J; Chambers LM; Carr C; Michener CM; Yao M; Beavis A; Yen TT; Stone RL; Wethington SL; Fader AN; Burkett WC; Richardson DL; Staley AS; Ahn S; Gehrig PA; Torres D; Dowdy SC; Sullivan MW; Modesitt SC; Watson C; Veade A; Ehrisman J; Havrilesky L; Secord AA; Loreen A; Griffin K; Jackson A; Viswanathan A; Ricci S
Int J Gynecol Cancer; 2020 Nov; 30(11):1738-1747. PubMed ID: 32771986
[TBL] [Abstract][Full Text] [Related]
24. Oncological Outcomes of Stage II Endometrial Cancer: A Retrospective Analysis of 250 Cases.
Ozgul N; Boyraz G; Salman MC; Gultekin M; Yuce K; Ibrahimov A; Erturk A; Gungorduk K; Gulseren V; Sanci M; Turkmen O; Karalok A; Kimyon G; Turan T; Ozkan NT; Meydanli MM; Gungor T; Ayik H; Simsek T
Int J Gynecol Cancer; 2018 Jan; 28(1):161-167. PubMed ID: 28930810
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy, Radiation, or Combination Therapy for Stage III Uterine Cancer.
Syeda S; Chen L; Hou JY; Tergas AI; Khoury-Collado F; Melamed A; St Clair CM; Ananth CV; Neugut AI; Hershman DL; Wright JD
Obstet Gynecol; 2019 Jul; 134(1):17-29. PubMed ID: 31188310
[TBL] [Abstract][Full Text] [Related]
26. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.
Barney BM; Petersen IA; Mariani A; Dowdy SC; Bakkum-Gamez JN; Haddock MG
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):109-15. PubMed ID: 22543202
[TBL] [Abstract][Full Text] [Related]
27. Overuse of external beam radiotherapy for stage I endometrial cancer.
Wright JD; Margolis B; Hou JY; Burke WM; Tergas AI; Huang Y; Hu JC; Ananth CV; Neugut AI; Hershman DL
Am J Obstet Gynecol; 2016 Jul; 215(1):75.e1-7. PubMed ID: 26875941
[TBL] [Abstract][Full Text] [Related]
28. Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter?
Plante M; Stanleigh J; Renaud MC; Sebastianelli A; Grondin K; Grégoire J
Gynecol Oncol; 2017 Aug; 146(2):240-246. PubMed ID: 28577885
[TBL] [Abstract][Full Text] [Related]
29. Improved overall survival with adjuvant radiotherapy for high-intermediate and high risk Stage I endometrial cancer.
Harkenrider MM; Adams W; Block AM; Kliethermes S; Small W; Grover S
Radiother Oncol; 2017 Mar; 122(3):452-457. PubMed ID: 28012794
[TBL] [Abstract][Full Text] [Related]
30. Role of brachytherapy in stage III endometrial cancer treated with adjuvant chemotherapy: Identifying factors predictive of a survival benefit.
Xiang M; English DP; Kidd EA
Brachytherapy; 2021; 20(4):701-709. PubMed ID: 33781714
[TBL] [Abstract][Full Text] [Related]
31. Practice patterns and survival in FIGO 2009 stage 3B endometrial cancer.
Jou J; Charo L; Hom-Tedla M; Coakley K; Binder P; Saenz C; Eskander RN; McHale M; Plaxe S
Gynecol Oncol; 2021 Nov; 163(2):299-304. PubMed ID: 34561099
[TBL] [Abstract][Full Text] [Related]
32. American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review.
Harkenrider MM; Block AM; Alektiar KM; Gaffney DK; Jones E; Klopp A; Viswanathan AN; Small W
Brachytherapy; 2017; 16(1):95-108. PubMed ID: 27260082
[TBL] [Abstract][Full Text] [Related]
33. Trends in the utilization of adjuvant vaginal cuff brachytherapy and/or external beam radiation treatment in stage I and II endometrial cancer: a surveillance, epidemiology, and end-results study.
Patel MK; Cote ML; Ali-Fehmi R; Buekers T; Munkarah AR; Elshaikh MA
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):178-84. PubMed ID: 22014953
[TBL] [Abstract][Full Text] [Related]
34. Utilization and Role of Adjuvant Radiotherapy and Chemotherapy for Uterine Clear Cell Carcinoma: A National Cancer Data Base Analysis.
Xu KM; Gill BS; Balasubramani GK; Sukumvanich P; Kelley JL; Beriwal S
Int J Gynecol Cancer; 2016 Mar; 26(3):472-82. PubMed ID: 26825837
[TBL] [Abstract][Full Text] [Related]
35. Early stage papillary serous or clear cell carcinoma confined to or involving an endometrial polyp: outcomes with and without adjuvant therapy.
Chang-Halpenny CN; Natarajan S; Hwang-Graziano J
Gynecol Oncol; 2013 Dec; 131(3):598-603. PubMed ID: 24135679
[TBL] [Abstract][Full Text] [Related]
36. Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients.
Hsieh HY; Wang L; Lu CH; Lin JC; Chen CC
J Formos Med Assoc; 2018 Jul; 117(7):613-620. PubMed ID: 28867455
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant therapy of uterine clear cell carcinoma: a review.
Xu Y; Hanna RK; Elshaikh MA
Arch Gynecol Obstet; 2016 Mar; 293(3):485-92. PubMed ID: 26626183
[TBL] [Abstract][Full Text] [Related]
38. Incorporation of vaginal brachytherapy to external beam radiotherapy in adjuvant therapy for high-risk early-stage cervical cancer: A comparative study.
Ragab OM; Mehta S; Nusbaum DJ; Shimada M; Brunette LL; Roman LD; Matsuo K
Brachytherapy; 2022; 21(2):141-150. PubMed ID: 34756697
[TBL] [Abstract][Full Text] [Related]
39. Compliance with adjuvant treatment guidelines in endometrial cancer: room for improvement in high risk patients.
Eggink FA; Mom CH; Boll D; Ezendam NPM; Kruitwagen RFPM; Pijnenborg JMA; van der Aa MA; Nijman HW
Gynecol Oncol; 2017 Aug; 146(2):380-385. PubMed ID: 28552255
[TBL] [Abstract][Full Text] [Related]
40. Addition of External Beam Radiation Therapy to Adjuvant Chemotherapy for Patients With Stage IIIC Uterine Endometrioid Carcinoma: Utilization and Outcomes.
Nasioudis D; Taunk NK; Ko EM; Haggerty AF; Cory L; Giuntoli RL; Kim SH; Latif NA
Am J Clin Oncol; 2022 Sep; 45(9):373-378. PubMed ID: 35926158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]